Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Directors of Bansisons Tea Industries Ltd met on November 19, 2025 and approved several major decisions. First, the company plans to change its name to either 'Quantum Care Pharmachem Limited' or 'Novyra Pharmachem Limited', signalling a possible shift away from its tea business toward pharma/chem. Second, the Board approved changing the Object Clause of its Memorandum of Association, also pointing to a business pivot. Third, the Board approved the sale of company land under Section 180(1)(a) of the Companies Act. All three items require shareholder approval via Postal Ballot. Additionally, Independent Director Mrs. Mamy Ghosh (DIN: 06532484) resigned effective November 19, 2025, citing pre-occupation. Mrs. Rupal Patel was appointed as Scrutinizer for the postal ballot process.
This is a significant transformation event – the name change and object clause shift strongly suggest the company is exiting or winding down its tea business and pivoting to pharma/chem. The land sale could generate cash for this transition. Shareholders will need to approve these changes via postal ballot. The stock could see volatility as the market digests this potential business overhaul.